Platelet-Derived Factors Enhance Hepatic Endothelial Fenestration and Reduce Early Metabolic Liver Disease
BACKGROUND: Although studies have highlighted the impact of antiplatelet therapies on metabolic dysfunction-associated steatotic liver disease (MASLD), how platelets are involved in liver metabolic dysregulation, especially in the initiation of the disease and its early progression, still remains ill-defined. METHODS: We used nutritional preclinical murine models that exhibit steatosis and early metabolic dysfunction-associated steatohepatitis combined with genetic or pharmacological approaches to modulate platelet count and activation. RESULTS: Our study is the first to reveal a protective role for blood platelets in maintaining liver homeostasis during the early stages of MASLD. We demonstrate that platelets safeguard the liver microenvironment by mitigating 2 key pathological features of early MASLD, lipid accumulation, and inflammation. Platelets accumulate in liver sinusoidal microvessels under steatosis and metabolic dysfunction-associated steatohepatitis, and ameliorate these disease stages by promoting hepatic vascular permeability and enhancing the fenestration of liver sinusoidal microvessels. Critically, we identify that platelets directly regulate liver sinusoidal endothelial cell activation and fenestration, a vital component of liver microvascular function. Mechanistically, this protective effect is mediated through platelet releasate, which increases liver sinusoidal endothelial cell fenestration via an autocrine nitric oxide-dependent signaling pathway. CONCLUSIONS: This study uncovers a novel protective role of platelets in the early stages of MASLD by modulating the phenotype of liver sinusoidal endothelial cells and preserving microvascular integrity through their releasate. These findings challenge the prevailing view of platelets as solely detrimental in MASLD and raise important considerations for the timing of antiplatelet therapies in MASLD management.
Authors
- Thierry Sulpice
- Maxime Borret
- Catherine Angénieux (ORCID: https://orcid.org/0000-0002-0475-1165)
- Emma Lefrançais (ORCID: https://orcid.org/0000-0003-0489-9298)
- Alicia Vauclard (ORCID: https://orcid.org/0000-0002-7837-6687)
- Isabelle Fourquaux (ORCID: https://orcid.org/0009-0000-0944-7683)
- Jean‐Philippe Pradère (ORCID: https://orcid.org/0000-0003-1734-1429)
- Laurence Gamet‐Payrastre (ORCID: https://orcid.org/0000-0003-1681-8491)
- Gaëtan Chicanne (ORCID: https://orcid.org/0000-0002-7081-2595)
- Arnaud Polizzi (ORCID: https://orcid.org/0000-0003-1986-2770)
- Mathieu Vigneau
- Marie Bellio (ORCID: https://orcid.org/0000-0002-7471-0983)
- Claude Knauf (ORCID: https://orcid.org/0000-0001-5213-5378)
- Blandine Maître (ORCID: https://orcid.org/0000-0002-3264-7330)
- Sonia Séverin (ORCID: https://orcid.org/0000-0002-1566-2619)
- Élodie Riant
- François Briand (ORCID: https://orcid.org/0000-0002-6771-6252)
- Bernard Payrastre (ORCID: https://orcid.org/0000-0002-8693-0190)
- Hervé Guillou (ORCID: https://orcid.org/0000-0002-5363-9081)
- Laetitia Pieruccioni
- Marine Fellmann
- Anne Abot
- Mathilde Miquel
- Claire Congnet
- Philippe Valet
Institutions
- Centre National de la Recherche Scientifique (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Inserm (FR)
- École Nationale Vétérinaire de Toulouse (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Physiogenex (France) (FR)
- Institut de Pharmacologie et de Biologie Structurale (FR)
- Toxicologie Alimentaire (FR)
- Institut de Recherche en Santé Digestive (FR)
- Hôpital Rangueil (FR)
- Établissement Français du Sang (FR)
- Institut des Maladies Métaboliques et Cardiovasculaires (FR)
- RESTORE (FR)
- Biologie et pharmacologie des plaquettes sanguines : hémostase, thrombose, transfusion (FR)
- Université de Toulouse (FR)
- Université de Strasbourg (FR)
Publication Details
- Journal
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1161/atvbaha.125.323653
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00